Impurity fingerprints for the identification of counterfeit medicines-A feasibility study

Analytica Chimica Acta

Volumn 701, Issue 2, 2011, Pages 224-231

  Sacré, Pierre Yves ^a,d   Deconinck, Eric ^a   Daszykowski, Michal ^b   Courselle, Patricia ^a   Vancauwenberghe, Roy ^c   Chiap, Patrice ^d   Crommen, Jacques ^e   De Beer, Jacques O ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY OF SILESIA   (Poland)

^c Federal Agency for Medicines and Health Products Belgium   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Classification; Counterfeit; Fingerprints; Impurities; Phosphodiesterase type 5 inhibitors

Indexed keywords

CHEMICAL COMPOSITIONS; CLASSIFICATION RATES; COUNTERFEIT; COUNTERFEIT DRUGS; CROSS VALIDATION; DISCRIMINANT PARTIAL LEAST SQUARES; EXPLORATORY ANALYSIS; FEASIBILITY STUDIES; FINGERPRINTS; GOOD MANUFACTURING PRACTICES; HPLC-UV; IMPURITY PROFILE; K-NEAREST NEIGHBOURS; PHOSPHODIESTERASES; PUBLIC HEALTH; TWO CLASSIFICATION; VALIDATION SETS;

CHROMATOGRAPHIC ANALYSIS; IMPURITIES; TEACHING;

CRIME;

COUNTERFEIT DRUG; ILLICIT DRUG; SILDENAFIL; TADALAFIL;

ARTICLE; CHROMATOGRAPHY; CLASSIFICATION ALGORITHM; CLASSIFIER; CONTROLLED STUDY; DATA ANALYSIS; DRUG CLASSIFICATION; DRUG DETERMINATION; DRUG PURIFICATION; DRUG QUALITY; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ALGORITHMS; CARBOLINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COUNTERFEIT DRUGS; DISCRIMINANT ANALYSIS; DRUG CONTAMINATION; FEASIBILITY STUDIES; LEAST-SQUARES ANALYSIS; PIPERAZINES; PRINCIPAL COMPONENT ANALYSIS; PURINES; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFONES; TABLETS;

EID: 79960746214     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2011.05.041     Document Type: Article

References (34)

1. Deisingh A.K. Analyst 2005, 130:271-279.
2. WHO, Fact sheet no. 275 Medicines: counterfeit medicines, January 2010. http://www.who.int/mediacentre/factsheets/fs275/en/index.html.
3. EAASM, The counterfeiting superhighway report, Surrey, 2008.
4. Kovaleski J., Kraut B., Mattiuz A., Giangiulio M., Brobst G., Cagno W., Kulkarni P., Rauch T. Adv. Drug Deliv. Rev. 2007, 59:56-63.
5. Häberli A., Girard P., Low M.Y., Ge X. J. Pharm. Biomed. Anal. 2010, 53:24-28.
6. Bigler P., Brenneisen R. J. Pharm. Biomed. Anal. 2009, 49:1060-1064.
7. Alonso-Salces R.M., Héberger K., Holland M.V., Moreno-Rojas J.M., Mariani C., Bellan G., Reniero F., Guillou C. Food Chem. 2010, 118:956-965.
8. Silvestre V., Maroga Mboula V., Jouitteau C., Akoka S., Robins R.J., Remaud G.S. J. Pharm. Biomed. Anal. 2009, 50:336-341.
9. Roggo Y., Roeseler C., Ulmschneider M. J. Pharm. Biomed. Anal. 2004, 36:777-786.
10. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., de Kaste D. J. Pharm. Biomed. Anal. 2006, 40:840-849.
11. Scafi S.H.F., Pasquini C. Analyst 2001, 126:2218-2224.
12. Zhu H., Wang Y., Liang H., Chen Q., Zhao P., Tao J. Talanta 2010, 81:129-135.
13. Yap K.Y.-L., Chan S.Y., Lim C.S. Food Res. Int. 2007, 40:643-652.
14. Dumarey M., van Nederkassel A.M., Stanimirova I., Daszykowski M., Bensaid F., Lees M., Martin G.J., Desmurs J.R., Smeyers-Verbeke J., Vander Heyden Y. Anal. Chim. Acta 2009, 655:43-51.
15. van Nederkassel A.M., Xu C.J., Lancelin P., Sarraf M., MacKenzie D.A., Walton N.J., Bensaid F., Lees M., Martin G.J., Desmurs J.R., Massart D.L., Smeyers-Verbeke J., Vander Heyden Y. J. Chromatogr. A 2006, 1120:291-298.
16. Ni Y., Lai Y., Brandes S., Kokot S. Anal. Chim. Acta 2009, 647:149-158.
17. Lian H., Wei Y. Talanta 2007, 71:264-269.
18. Nicolas E.C., Scholz T.H. J. Pharm. Biomed. Anal. 1998, 16:825-836.
19. Carrier D., Eckers C., Arnoult T., Thurston T., Major H. Rapid Commun. Mass Spectrom. 2007, 21:3946-3948.
20. Jiang Y., David B., Tu P., Barbin Y. Anal. Chim. Acta 2010, 657:9-18.
21. Xiaohui F., Yi W., Yiyu C. J. Pharm. Biomed. Anal. 2006, 40:591-597.
22. Hu P., Liang Q.L., Luo G.A., Zhao Z.Z., Jiang Z.H. Chem. Pharm. Bull. 2005, 53:677-683.
23. Han C., Shen Y., Chen J., Lee F.S.-C., Wang X. J. Chromatogr. B 2008, 862:125-131.
24. Lee J.S., Chung H.S., Kuwayama K., Inoue H., Lee M.Y., Park J.H. Anal. Chim. Acta 2008, 619:20-25.
25. Xu C.-J., Liang Y.-Z., Chau F.-T., Vander Heyden Y. J. Chromatogr. A 2006, 1134:253-259.
26. Daszykowski M., Sajewicz M., Rzepa J., Hajnos M., Staszek D., Wojtal L., Kowalska T., Waksmundzka-Hajnos M., Walczak B. Acta Chromatogr. 2009, 4:513-530.
27. European Directorate for the Quality of Medicines Draft monography of sildenafil citrate. Pharmeuropa 2011, 23:381-383.
28. European Directorate for the Quality of Medicines Draft monography of tadalafil. Pharmeuropa 2010, 22:328-332.
29. Daszykowski M., Walczak B. Trends Anal. Chem. 2006, 25:1081-1096.
30. Daszykowski M., Walczak B. J. Chromatogr. A 2007, 1176:1-11.
31. Daszykowski M., Walczak B., Massart D.L. Chemom. Intell. Lab. 2003, 65:97-112.
32. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-verbeke J. Handbook of Chemometrics and Qualimetrics-Part A 1997, Elsevier Science, Amsterdam.
33. Kennard R.W., Stone L.A. Technometrics 1969, 11:137-148.
34. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-verbeke J. Handbook of Chemometrics and Qualimetrics-Part B 1997, Elsevier Science, Amsterdam.